ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd (SHA:603976)
21.62
-0.30 (-1.37%)
May 28, 2026, 3:00 PM CST
SHA:603976 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 207.28 | 325.08 | 108.9 | 187.62 | 212.43 | 392.17 |
Short-Term Investments | - | 156.59 | - | - | - | - |
Trading Asset Securities | 150 | - | 140.58 | 250.11 | 159.06 | 254.76 |
Cash & Short-Term Investments | 357.28 | 481.67 | 249.48 | 437.73 | 371.49 | 646.93 |
Cash Growth | 31.69% | 93.07% | -43.01% | 17.83% | -42.58% | 140.23% |
Accounts Receivable | 396.42 | 338.59 | 364.58 | 397.91 | 355.53 | 298.37 |
Other Receivables | 4.61 | 4.29 | 4.15 | 5.51 | 20.26 | 2.86 |
Receivables | 401.03 | 342.88 | 368.73 | 403.42 | 375.8 | 301.23 |
Inventory | 192.29 | 230.39 | 250.48 | 197.14 | 209.43 | 190.5 |
Other Current Assets | 169.88 | 8.45 | 7.17 | 12.87 | 35.03 | 12.45 |
Total Current Assets | 1,120 | 1,063 | 875.86 | 1,051 | 991.75 | 1,151 |
Property, Plant & Equipment | 758.45 | 782.23 | 859.67 | 919.49 | 909.85 | 665.86 |
Long-Term Investments | - | - | 0.05 | 0.05 | 0.05 | 0.05 |
Other Intangible Assets | 38.05 | 38.31 | 39.36 | 40.41 | 41.6 | 42.98 |
Long-Term Deferred Tax Assets | 9.87 | 9.34 | 8.82 | 12.65 | 1.13 | 5.89 |
Long-Term Deferred Charges | 1.45 | 1.64 | 2.23 | 2.74 | 3.9 | 4.27 |
Other Long-Term Assets | 18.85 | 6.66 | 170.82 | 16.38 | 59.41 | 90.33 |
Total Assets | 1,947 | 1,902 | 1,957 | 2,043 | 2,008 | 1,960 |
Accounts Payable | 220.2 | 191.8 | 240.47 | 313.88 | 296.65 | 278.36 |
Accrued Expenses | 12.97 | 25.58 | 22.81 | 23.82 | 20.68 | 26.4 |
Short-Term Debt | - | - | - | 30 | 60 | 50 |
Current Portion of Leases | 0.06 | 0.06 | 0.06 | 0.2 | 0.37 | 0.32 |
Current Income Taxes Payable | 10.43 | 1.45 | 0.92 | 3.3 | 0.98 | 13.28 |
Current Unearned Revenue | 5.98 | 4.19 | 3.39 | 4.61 | 6.77 | 6.76 |
Other Current Liabilities | 7.16 | 2.06 | 2.43 | 3.63 | 4.22 | 3.06 |
Total Current Liabilities | 256.8 | 225.14 | 270.08 | 379.44 | 389.66 | 378.18 |
Long-Term Debt | 451.32 | 445.94 | 431.99 | 416.25 | 399.27 | 382.32 |
Long-Term Leases | 0.01 | 0.01 | 0.03 | 0.06 | 0.54 | 0.91 |
Long-Term Unearned Revenue | 27.02 | 25.3 | 31.3 | 31.61 | 28.63 | 30.72 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 5.37 | 2.4 |
Total Liabilities | 735.16 | 696.39 | 733.4 | 827.37 | 823.47 | 794.53 |
Common Stock | 151.2 | 151.2 | 151.2 | 151.2 | 151.2 | 151.2 |
Additional Paid-In Capital | 555.71 | 555.71 | 555.63 | 555.63 | 555.63 | 555.59 |
Retained Earnings | 480.76 | 473.93 | 492.22 | 484.34 | 453.03 | 434.82 |
Comprehensive Income & Other | 24.34 | 24.34 | 24.35 | 24.35 | 24.35 | 24.35 |
Shareholders' Equity | 1,212 | 1,205 | 1,223 | 1,216 | 1,184 | 1,166 |
Total Liabilities & Equity | 1,947 | 1,902 | 1,957 | 2,043 | 2,008 | 1,960 |
Total Debt | 451.39 | 446.01 | 432.08 | 446.51 | 460.17 | 433.55 |
Net Cash (Debt) | -94.11 | 35.66 | -182.6 | -8.78 | -88.68 | 213.38 |
Net Cash Growth | - | - | - | - | - | -2.81% |
Net Cash Per Share | -0.67 | 0.25 | -1.20 | -0.06 | -0.59 | 1.42 |
Filing Date Shares Outstanding | 151.2 | 151.2 | 151.2 | 151.2 | 151.2 | 151.2 |
Total Common Shares Outstanding | 151.2 | 151.2 | 151.2 | 151.2 | 151.2 | 151.2 |
Working Capital | 863.69 | 838.26 | 605.78 | 671.72 | 602.08 | 772.92 |
Book Value Per Share | 8.02 | 7.97 | 8.09 | 8.04 | 7.83 | 7.71 |
Tangible Book Value | 1,174 | 1,167 | 1,184 | 1,175 | 1,143 | 1,123 |
Tangible Book Value Per Share | 7.76 | 7.72 | 7.83 | 7.77 | 7.56 | 7.43 |
Buildings | - | 459.38 | 466.94 | 467.67 | 362.71 | 359.42 |
Machinery | - | 933.13 | 902.78 | 926.75 | 734.29 | 608.03 |
Construction In Progress | - | 35.27 | 52.03 | 10.97 | 198.58 | 20.21 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.